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Ankylosing spondylitis (AS) is a human leukocyte anti-
gen (HLA)-B27-associated disease that is character-
ized by chronic progressive inflammation in the axial
joints and entheses (the ligaments and tendon attach-
ments in bone). The disease has late involvement in
other organs including the eyes, lungs, skin and kid-
ney. Juvenile-onset spondyloarthropathies (JSpAs) are
a group of HLA-B27-associated disorders in children
and teenagers younger than 16 years of age, and which
are characterized by asymmetric arthritis and enthesi-
tis largely in the lower limbs. JSpAs encompass several
well-defined disease entities including seronegative
enthesopathy and arthropathy (SEA) syndrome,1 reac-
tive arthritis, Reiter disease, inflammatory bowel disease-
associated arthropathies, psoriatic arthropathy and
juvenile ankylosing spondylitis (JAS). Unlike adult-
onset AS (AAS), JAS typically presents as inflamma-
tion around entheses. It is also highly associated with
the HLA-B27 antigen.2 As much as 90% of JAS
patients have been detected to have HLA-B27, but
only about 60% of children with JSpAs have been
found to be HLA-B27-positive. Nevertheless, the pres-
ence or absence of HLA-B27 cannot be regarded as a
reliable criterion to establish or refute diagnosis of
JAS.2 In many patients, the specific diagnosis remains
“undifferentiated”, with some of them fulfilling crite-
ria for SEA syndrome3 or more bizarre presentations
of undifferentiated spondyloarthropathy. Over time,
some of these children with undifferentiated spondy-
loarthropathy develop definite sacroiliitis, fulfilling
the criteria for JAS.4 It has been estimated that JAS
accounts for about 20% of JSpAs.
In general, spondyloarthropathy (SpA) rarely 
occurs before the second decade of life. On the other
hand, typical AAS usually starts at around 15 years 
of age. JAS is much more common in boys than in
girls, but the other subsets of JSpAs have a more
equal sex distribution. A family history of similar pre-
sentations is frequently present, even in those who do
not have HLA-B27 antigen.5 A prospective pediatric
rheumatology registry for JSpAs and other rheumatic
diseases has shown incidences of 53% for juvenile
rheumatoid arthritis, 13% for JSpAs, 10% for vasculi-
tides, 6% for systemic lupus erythematosus, 5% for
isolated Raynaud’s phenomenon, 5% for dermato-
myositis/polymyositis and 2% for scleroderma among
1,742 children who were diagnosed with rheumatic
diseases.6 Thus, well-recognized juvenile rheumatoid
arthritis accounted for more than half of the pediatric
patients with rheumatic presentation. Over time,
there would be patients with JSpAs turning out to
have rheumatoid arthritis. However, those data may
be biased by the failure of many children with mild
SpA to be properly recognized and referred to
rheumatologists.
The International League Against Rheumatism has
proposed another term for this group of diseases in
young age, i.e. juvenile idiopathic arthritides (JIAs),7,8
which must fulfill at least 2 of the following criteria
including tenderness in a sacroiliac joint and/or inflam-
matory spinal pain, presence of HLA-B27 antigen,
1st- or 2nd-degree next-of-kin with medically confirmed
HLA-B27-associated disease, anterior uveitis associated
with pain, red eyes, photophobia, or onset of arthritis
after the age of 8 years in boys. In these proposed diag-
nostic criteria, 2 of the conditions should be excluded
to diagnose JIA, i.e. psoriasis recognized in the patient’s
1st- or 2nd-degree next-of-kin or the presence of sys-
temic arthritis.
Except for joint inflammation and enthesitis,
patients with JSpAs may also frequently present with
extra-articular symptoms in the eyes, gut, skin and
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mucosa. These include uveitis,9 scleritis, secondary
amyloidosis, Henoch-Schönlein purpura, IgA neph-
ropathy and secondary sicca syndrome. Despite the
difficulties in diagnosing and differentiating JSpAs
from other juvenile arthritides, there has been signifi-
cantly increased recognition and reporting of this
group of diseases in recent years.
The prevalence, incidence, or clinical features of
AAS or its relevance to SpA in Taiwan has not been
well recognized, although scattered studies regarding
the clinical manifestation and their genetic background
have been sporadically reported.10–12 In the November
2009 issue of the Journal of the Chinese Medical
Association, Lin et al13 report a comparison between
AAS and JAS. They analyzed 169 patients with AS,
among whom 47 patients were recognized to have
JAS at presentation. Both groups of patients had sim-
ilar sex distribution, duration in delay of diagnosis
and duration of the natural disease course. The JAS
patients tended to develop initial inflammation around
entheses or peripheral joints, while AAS patients had
their initial manifestations in the axial joints. These
findings were similar to those reported previously for
Caucasians.1,2 In particular, onset of both JAS and
AAS frequently coincided with overzealous physical
exercise or physical trauma, indicating that the patho-
genetic mechanism of SpA may be quite different
from that of rheumatoid arthritis, which is character-
ized by intense lymphocyte infiltration in the synovium.
On the other hand, this might be alternatively inter-
preted as the reason for delay in diagnosis. Indeed,
the onset of SpA symptoms early in the second decade
coincides with a period of steeply increased sports
activity. Children with SpA are therefore commonly
thought to have recurrent sprains or strains, resulting
in ignorance of the true diagnosis.
Regarding the late manifestations in extra-articular
organs, IgA nephropathy seemed to occur more fre-
quently in JAS patients. It is unclear whether this was
caused by longer incubation time for the development
of renal inflammation in JAS patients or other uniden-
tified environmental and genetic factors. After all, the
sample size was too small to draw a definite conclu-
sion. The drawback of the present investigation is that
Lin et al were unable to include patients followed-up
in the pediatric clinic. This dilemma was similar to that
encountered previously by a pediatric rheumatology
registry in New England.6 It might have led to under-
estimation of the JAS incidence in the 169 studied
patients. In addition, the prevalence of rheumatoid
factor in serum or actual rheumatoid activity in these
patients was not known. Previous investigations have
shown that a substantial percentage of JIA or JSpA
patients will eventually evolve to full-blown rheuma-
toid arthritis. This cohort of 169 patients deserves
further long-term follow-up and evaluation to observe
the disease outcome and complications. Nevertheless,
their data may still shed some light on the study of
juvenile arthritis because the true incidence and
prevalence of SpA in Taiwan is still unknown.
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